長江健康(002435.SZ)連續3個漲停 已優先安排生產抗疫一線急需的相關抗感染藥品
格隆匯2月7日丨長江健康(002435.SZ)公佈,公司股票於2020年2月5日、2月6日、2月7日三個交易日收盤價漲幅偏離值累計達到20%以上,根據《深圳證券交易所交易規則》的相關規定,屬於股票交易異常波動的情形。
今年春節前後,新型冠狀病毒肺炎疫情迅速蔓延。疫情發生後,公司快速啟動緊急預案,在做好自身防控工作的同時,緊急組織捐贈了注射用頭孢他啶、注射用阿奇黴素和注射用甲磺酸帕珠沙星等抗感染藥品,積極履行醫藥企業的社會責任。
公司留意到近期“新型冠狀病毒感染的肺炎”相關媒體報道;目前,公司已優先安排生產抗疫一線急需的相關抗感染藥品。山東華信製藥集團股份有限公司持有250ml利巴韋林葡萄糖注射液的批准文號,但目前暫無生產;後續公司將進一步加強關注,如有需要,公司將按照主管部門要求,做好復產的相關手續,具有一定的不確定性,請廣大投資者理性投資,注意風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.